Cytokine Release Syndrome in the Immunotherapy of Hematological Malignancies: The Biology behind and Possible Clinical Consequences
Cytokine release syndrome (CRS) is an acute systemic inflammatory syndrome characterized by fever and multiple organ dysfunction associated with (i) chimeric antigen receptor (CAR)-T cell therapy, (ii) therapeutic antibodies, and (iii) haploidentical allogeneic stem cell transplantation (haplo-allo-...
Enregistré dans:
| Auteurs principaux: | Tor Henrik Anderson Tvedt, Anh Khoi Vo, Øystein Bruserud, Håkon Reikvam |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
MDPI AG
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/f0af6da2777f473186d1684ee863dffe |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy
par: Yan-Ruide Li, et autres
Publié: (2021) -
Early Myeloid Derived Suppressor Cells (eMDSCs) Are Associated With High Donor Myeloid Chimerism Following Haploidentical HSCT for Sickle Cell Disease
par: Deepali K. Bhat, et autres
Publié: (2021) -
Major advances in the treatment of multiple myeloma in American Society of Hematology annual meeting 2020
par: Jianhua Du, et autres
Publié: (2021) -
CELLULAR IMMUNOTHERAPY: A MODERN APPROACH TO TREATMENT OF ONCOLOGICAL DISEASES
par: Yu. N. Lezhnin, et autres
Publié: (2018) -
Iron chelation therapy improves hematopoiesis in patients with hematological malignancy after hematopoietic stem cell transplantation
par: ZENG Cong, et autres
Publié: (2021)